Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-11-13

FDA Approved: CIMETIDINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved Teva's supplemental application for cimetidine, resulting in an expanded label/approval for the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cimetidine (CIMETIDINE)

Snippet

SUPPL AP for CIMETIDINE (CIMETIDINE)